CD8A and neoplasm: Treatment with aPDL1-GEM@Gel not only significantly inhibited tumor growth in the B16F10 mouse melanoma tumor model, but also increased infiltration of CD4+ and CD8+ T-cells and induced systematic immune responses (37).